Vimta Labs Stock Screener | Share Price & Fundamental Analysis
VIMTALABS
Healthcare Technology
Screen Vimta Labs share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹619.55
▲
9.35 (1.53%)
Share Price BSE
₹619.15
▲
9.90 (1.62%)
Market Cap
₹2,714.94 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
7.81
EPS (TTM)
₹18.51
Dividend Yield
0.17%
Debt to Equity
0.06
52W High
₹876.00
52W Low
₹399.50
Operating Margin
37.00%
Profit Margin
23.16%
Revenue (TTM)
₹95.00
EBITDA
₹38.00
Net Income
₹22.00
Total Assets
₹400.00
Total Equity
₹320.00
Vimta Labs Share Price History - Stock Screener Chart
Screen VIMTALABS historical share price movements with interactive charts. Analyze price trends and patterns.
Vimta Labs Company Profile - Fundamental Screener
Screen Vimta Labs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for VIMTALABS shares.
Sector
Healthcare
Industry
Healthcare Technology
Sub-Sector
Healthcare Technology
Segment
E
ISIN
INE579C01029
Vimta Labs Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen VIMTALABS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Total Assets | 400 | 362 | 307 | 274 | 246 |
| Current Assets | 158 | 164 | 124 | 111 | 96 |
| Fixed Assets | 171 | 175 | 169 | 135 | 138 |
| Liabilities | |||||
| Total Liabilities | 400 | 362 | 307 | 274 | 246 |
| Current Liabilities | 26 | 23 | 26 | 26 | 15 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||
| Total Equity | 320 | 282 | 234 | 194 | 173 |
| Share Capital | 4 | 4 | 4 | 4 | 4 |
| Reserves & Surplus | 315 | 277 | 230 | 190 | 169 |
Screen VIMTALABS income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun | 2022-Mar | 2021-Dec | 2021-Sept | 2021-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 95 | 85 | 76 | 80 | 75 | 68 | 84 | 83 | 79 | 81 | 80 | 75 | 68 | 76 | 62 |
| Expenses | 57 | 57 | 51 | 55 | 53 | 50 | 59 | 58 | 56 | 55 | 55 | 51 | 47 | 57 | 45 |
| EBITDA | 38 | 29 | 25 | 25 | 23 | 18 | 25 | 25 | 23 | 26 | 25 | 24 | 21 | 19 | 17 |
| Operating Profit % | 37.00% | 33.00% | 32.00% | 31.00% | 29.00% | 24.00% | 30.00% | 30.00% | 28.00% | 32.00% | 30.00% | 31.00% | 31.00% | 25.00% | 27.00% |
| Depreciation | 10 | 8 | 8 | 8 | 8 | 9 | 9 | 8 | 8 | 8 | 7 | 7 | 6 | 6 | 6 |
| Interest | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| Profit Before Tax | 28 | 20 | 17 | 16 | 14 | 8 | 16 | 17 | 14 | 18 | 17 | 16 | 16 | 13 | 11 |
| Tax | 6 | 5 | 4 | 4 | 3 | 2 | 4 | 4 | 4 | 5 | 5 | 4 | 4 | 3 | 3 |
| Net Profit | 22 | 15 | 12 | 12 | 10 | 6 | 12 | 13 | 10 | 13 | 12 | 12 | 12 | 10 | 8 |
| EPS | 9.65 | 6.88 | 5.54 | 5.58 | 3.61 | 2.86 | 5.51 | 5.73 | 4.62 | 5.97 | 5.45 | 5.36 | 5.28 | 4.41 | 3.65 |
Vimta Labs Cash Flow Screener - Liquidity Fundamentals
Screen VIMTALABS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|
| Operating Activities | 61 | 88 | 59 | 37 | 24 |
| Investing Activities | -76 | -57 | -38 | -32 | -21 |
| Financing Activities | -2 | -11 | -17 | -5 | -1 |
| Net Cash Flow | -17 | 20 | 5 | 1 | 3 |
Screen VIMTALABS shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 36.70% | 36.67% | 35.99% | 36.92% | 36.89% | 36.89% | 36.76% | 37.24% |
| FII Holding | 3.66% | 3.49% | 4.33% | 5.13% | 5.16% | 3.31% | 3.81% | 0.00% |
| DII Holding | 1.43% | 1.42% | 0.87% | 1.50% | 1.49% | 0.00% | 1.16% | 2.14% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 25.17% | 24.02% | 24.62% | 23.08% | 23.13% | 26.53% | 25.09% | 25.19% |
| Other Holding | 33.03% | 34.40% | 34.18% | 33.37% | 33.33% | 33.27% | 33.18% | 35.43% |
| Shareholder Count | 26,183 | 29,867 | 55,933 | 18,550 | 19,054 | 20,114 | 21,156 | 17,162 |
Vimta Labs Dividend Screener - Share Yield Analysis
Screen VIMTALABS dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹2.00 | 0.33% |
| 2024-March | ₹2.00 | 0.40% |
| 2023-March | ₹2.00 | 0.90% |
| 2022-March | ₹2.00 | 1.27% |
| 2021-March | ₹2.00 | 1.27% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹2.00 | 6.70% |
| 2018-March | ₹2.00 | 2.01% |
| 2017-March | ₹0.00 | 0.00% |
Vimta Labs Index Membership - Market Screener Classification
Screen VIMTALABS by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Vimta Labs Market Events Screener - Corporate Actions
Screen VIMTALABS market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-03 | 2025-11-03 | Quarterly Result Announcement | NA | 8.45% |
| 2025-07-17 | 2025-07-17 | Quarterly Result Announcement | NA | 4.92% |
| 2025-06-13 | 2025-06-13 | Bonus | 1:1 | 6.85% |
| 2025-06-06 | 2025-06-06 | Annual General Meeting | NA | -8.46% |
| 2025-05-30 | 2025-05-30 | Dividend | ₹ 2.00 /share | -9.68% |
| 2025-04-28 | 2025-04-28 | Quarterly Result Announcement | NA | 10.85% |
| 2025-01-24 | 2025-01-24 | Quarterly Result Announcement | NA | 1.52% |
| 2024-11-08 | 2024-11-08 | Quarterly Result Announcement | NA | 0.98% |
| 2024-07-18 | 2024-07-18 | Annual General Meeting | NA | 14.19% |
| 2024-07-11 | 2024-07-12 | Dividend | ₹ 2.00 /share | 4.52% |
| 2023-06-21 | 2023-06-22 | Dividend | ₹ 2.00 /share | 6.53% |
| 2022-06-16 | 2022-06-18 | Dividend | ₹ 2.00 /share | -2.05% |
| 2021-06-25 | 2021-06-28 | Dividend | ₹ 2.00 /share | -0.96% |
Vimta Labs Competitors Screener - Peer Comparison
Screen VIMTALABS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Syngene International | 26,310 | 55.90 | 3,714 | 3.77% | 496 | 51.46 |
| Indegene | 12,637 | 28.01 | 2,947 | 10.53% | 407 | 42.94 |
| Suven Life Sciences | 3,796 | -17.74 | 18 | -46.34% | -161 | 39.99 |
| Vimta Labs | 2,715 | 43.62 | 322 | 0.22% | 41 | 44.90 |
| Take Solutions | 600 | 12.37 | 10 | 126.67% | 1 | 87.87 |
| Bilcare | 185 | -4.17 | 807 | 4.78% | -56 | 43.28 |
| Jeevan Scientific Technology | 103 | -22.71 | 48 | 17.87% | 0 | 62.49 |
| Adeshwar Meditex | 26 | 33.09 | 84 | 5.00% | 2 | 21.16 |
| Vanta Bioscience | 17 | -1.26 | 2 | -78.57% | -13 | 20.40 |
Vimta Labs Company Announcements - News Screener
Screen VIMTALABS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-03 | Closure of Trading Window | View |
| 2025-12-13 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-24 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-21 | Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements | View |
| 2025-11-17 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | View |
| 2025-11-11 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-11 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-10 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2025-11-04 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-03 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-03 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-03 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-03 | Q2 FY- 2025-26 - Unaudited Financial Results. | View |
| 2025-11-03 | Board Meeting Outcome for Q2 FY- 2025-26 - Unaudited Financial Results | View |
| 2025-10-28 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-10-28 | Board Meeting Intimation for Q2 FY2025-26- Financial Results - Board Meeting | View |
| 2025-10-14 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-30 | Closure of Trading Window | View |
| 2025-09-25 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-09-18 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |